Warfarin with Zomepirac Interaction Details


Brand Names Associated with Warfarin

  • Coumadin®
  • Jantoven®
  • Warfarin

Medical Content Editor
Last updated Nov 07, 2023


Curious for more information about this interaction?

Ask our pharmacists directly!

Reach out to us

Interaction Effect

An increased risk of bleeding


Interaction Summary

In vitro and in vivo studies indicate that zomepirac does not interfere with warfarin's hypoprothrombinemic effect, but zomepirac has transiently inhibited platelet function . The possibility of gastrointestinal bleeding must also be kept in mind whenever an NSAID is used in conjunction with an oral anticoagulant.


Severity

Moderate


Onset

Delayed


Evidence

Theoretical


How To Manage Interaction

Although there is no evidence that zomepirac at therapeutic doses would alter the anticoagulant effect of warfarin, caution should be exercised when these two drugs are used concurrently. Other NSAIDs have been shown to increase the hypoprothrombinemic response to warfarin. Monitor prothrombin times (PT) or international normalized ratios (INR) and watch patients for signs of bleeding, especially from the gastrointestinal tract.


Mechanism Of Interaction

Inhibition of platelet aggregation and gastric erosion


Literature Reports

A) Concomitant zomepirac and warfarin therapy had no effect on the anticoagulant response to warfarin in 16 healthy young male volunteers . Combined therapy with oral zomepirac 150 mg four times a day and warfarin in an initial dose of 15 mg, with adjustments to achieve prothrombin times of 150% to 200% of control values, resulted in no increase in prothrombin time. In addition, there were no significant differences observed in bleeding time, partial thromboplastin time, platelet count, or hematocrit and no adverse effects were reported. These data support in vitro studies demonstrating that although zomepirac is highly protein bound (98%), it is not displaced during concomitant warfarin administration .

Warfarin Overview

  • Warfarin is used to prevent blood clots from forming or growing larger in your blood and blood vessels. It is prescribed for people with certain types of irregular heartbeat, people with prosthetic (replacement or mechanical) heart valves, and people who have suffered a heart attack. Warfarin is also used to treat or prevent venous thrombosis (swelling and blood clot in a vein) and pulmonary embolism (a blood clot in the lung). Warfarin is in a class of medications called anticoagulants ('blood thinners'). It works by decreasing the clotting ability of the blood.

See More information Regarding Warfarin

Return To Our Drug Interaction Homepage


Feedback, Question Or Comment About This Information?

Ask , our medical editor, directly! He's always more than happy to assist.


Definitions

Severity Categories

Contraindicated

These drugs, generally, should not be used together simultaneously due to the high risk of severe adverse effects. Combining these medications can lead to dangerous health outcomes and should be strictly avoided unless otherwise instructed by your provider.


Major

This interaction could result in very serious and potentially life-threatening consequences. If you are taking this drug combination, it is very important to be under close medical supervision to minimize severe side effects and ensure your safety. It may be necessary to change a medication or dosage to prevent harm.


Moderate

This interaction has the potential to worsen your medical condition or alter the effectiveness of your treatment. It's important that you are monitored closely and you potentially may need to make adjustments in your treatment plan or drug dosage to maintain optimal health.


Minor

While this interaction is unlikely to cause significant problems, it could intensify side effects or reduce the effectiveness of one or both medications. Monitoring for changes in symptoms and your condition is recommended, and adjustments may be made if needed to manage any increased or more pronounced side effects.


Onset

Rapid: Onset of drug interaction typically occurs within 24 hours of co-administration.

Delayed: Onset of drug interaction typically occurs more than 24 hours after co-administration.


Evidence

Level of documentation of the interaction.

Established: The interaction is documented and substantiated in peer-reviewed medical literature.

Theoretical: This interaction is not fully supported by current medical evidence or well-documented sources, but it is based on known drug mechanisms, drug effects, and other relevant information.


How To Manage The Interaction

Provides a detailed discussion on how patients and clinicians can approach the identified drug interaction as well as offers guidance on what to expect and strategies to potentially mitigate the effects of the interaction. This may include recommendations on adjusting medication dosages, altering the timing of drug administration, or closely monitoring for specific symptoms.

It's important to note that all medical situations are unique, and management approaches should be tailored to individual circumstances. Patients should always consult their healthcare provider for personalized advice and guidance on managing drug interactions effectively.


Mechanism Of Interaction

The theorized or clinically determined reason (i.e., mechanism) why the drug-drug interaction occurs.


Disclaimer: The information provided on this page is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional regarding your specific circumstances and medical conditions.

Where Does Our Information Come From?

Information for our drug interactions is compiled from several drug compendia, including:

The prescribing information for each drug, as published on DailyMED, is also used. 

Individual drug-drug interaction detail pages contain references specific to that interaction. You can click on the reference number within brackets '[]' to see what reference was utilized.

The information posted is fact-checked by HelloPharmacist clinicians and reviewed quarterly.